プレマーケット: 2.04 0.01 +0.49%

Serina Therapeutics Inc (SER)

概要ニュース株価時系列ディスカッション予測

Serina Therapeutics Inc (SER) 最新ニュース

Serina Therapeutics Inc (SER)

Serina Therapeutics Inc (SER) 最新ニュース

Serina Therapeutics (SER) stock surges over 39% after hours—here's why - MSN

Market Review: What is the dividend yield of Serina Therapeutics IncWeekly Trend Recap & Verified Momentum Stock Alerts - baoquankhu1.vn

Take Profit: What is the dividend yield of Serina Therapeutics IncMarket Growth Report & Free High Return Stock Watch Alerts - baoquankhu1.vn

Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit - Sahm

Serina Therapeutics, Inc Announces Novel Lipid Nanoparticles Built On POZ Platform - marketscreener.com

Recap Report: Will PHUN be affected by tariffs2026 PreEarnings & Risk Controlled Swing Alerts - baoquankhu1.vn

Serina says its nanoparticle polymer avoided antibodies in rat study - Stock Titan

Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan - Sahm

Serina Therapeutics wins NYSE approval; 2027 listing compliance deadline set - MSN

Serina Therapeutics announces NYSE American acceptance of continued listing compliance plan - marketscreener.com

Serina Therapeutics Announces NYSE American Acceptance Of Continued Listing Compliance Plan - TradingView

SER Technical Analysis & Stock Price Forecast - Intellectia AI

Stock List: Research Stocks from Around the World - GuruFocus

Serina Therapeutics (SER) files 10-K amendment to correct auditor consent - stocktitan.net

New funding to support Serina’s SER-252 trial in advanced Parkinson’s - Parkinson's News Today

SER Stock Price and Chart — AMEX:SER - TradingView

Serina Therapeutics POZ Drug Delivery Platform: Technology Overview, Pipeline, and Intellectual Property Portfolio - Minichart

Serina Therapeutics' 2025 net loss widens as R&D expenses jump - TradingView

Serina Therapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights - marketscreener.com

Serina Therapeutics (NYSE: SER) posts 2025 loss while funding SER-252 trials - Stock Titan

[10-K] Serina Therapeutics, Inc. Fi... - Stock Titan

Serina Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener

Parkinson's drug candidate reaches patients as Serina lines up $30M - Stock Titan

Top Executive Makes Notable Move With Serina Therapeutics Stock - TipRanks

Serina Therapeutics CSO Moreadith sells $18,567 in stock - Investing.com

Serina Therapeutics CSO Moreadith sells $18,567 in stock By Investing.com - Investing.com Canada

Serina Therapeutics (SER) CSO exercises options then sells 6,500 shares - Stock Titan

Serina Therapeutics Raises Up to $30 Million to Advance SER-252 Parkinson’s Drug Trial and Secures Additional Funding Opportunities - Minichart

Serina Therapeutics to Present at 38th Annual Roth Conference - National Today

Serina Therapeutics to Present at the 38th Annual Roth Conference - Bitget

Serina Therapeutics Inc appoints Greg Bailey as co-chairman of boardSEC filing - MarketScreener

Serina Therapeutics IncAppoints Greg Bailey As Co-Chairman Of BoardSEC Filing - TradingView — Track All Markets

Serina Therapeutics (SER) lines up $30M private placement plus $33.3M warrant upside - Stock Titan

Serina Therapeutics Inc. Faces Stock Volatility Amid Economic Challenges - StocksToTrade

Risk Check: What is the dividend yield of Serina Therapeutics IncEarnings Recap Summary & Daily Profit Focused Stock Screening - baoquankhu1.vn

Serina Therapeutics secures up to $30M in private placement - MSN

Serina Therapeutics Insider Sells $97,500 in Stock - National Today

Top Serina Therapeutics Executive Makes Notable Stock Move - TipRanks

Serina Therapeutics CSO sells $97,500 in shares By Investing.com - Investing.com Canada

Serina Therapeutics (SER) CSO exercises options and sells 39,000 shares - Stock Titan

Serina Therapeutics Inc. Rallies on Dynamic Market Expansion Prospects - timothysykes.com

Serina Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | 2BO | US81751A1088 - marketscreener.com

Stock Market Today: Futures Drop Ahead Of 'Triple Witching' Session As Iran Threatens 'Zero Restraint'— FedEx, Super Micro In Focus (UPDATED) - Benzinga

Serina Therapeutics (SER) Stock Jumps 39% Following $63M Financing Deal and Leadership Announcement - MEXC

Serina Therapeutics (SER) Stock Climbs 39% on Private Placement and Greg Bailey Appointment - MEXC

Biotech Microcap Rockets After Securing Major Capital Infusion at Premium Valuation - The Globe and Mail

SER Stock Surges Amid Strategic Acquisitions and Partnerships - StocksToTrade

Serina Therapeutics (SER) Stock Soars 39% After Announcing $63M Funding and Leadership Boost - parameter.io

Serina Therapeutics (SER) Stock Soars 39% After $30M Funding Deal and Leadership Boost - MoneyCheck

Serina Therapeutics’ Stock Hits All-Time Low Amid Financial Challenges - timothysykes.com

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Serina Therapeutics (SER) Stock Surges Over 39% After Hours— Here's Why - Benzinga

Serina Therapeutics, Inc. Appoints Greg Bailey as Co-Chairman of the Board of Directors - marketscreener.com

SERに似た銘柄